CurrentEndo
Get Weekly

CurrentEndo coverage · page 17 of 55

Diabetes, Obesity and Metabolism

Briefs 641–680 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

  1. Diabetes Obes Metab

    Methylglyoxal‐derived hydroimidazolone ( MG ‐ H1 ) is a novel marker of insulin resistance in Japanese individuals, disturbing insulin signalling via mTORC2 in cultured myocytes

    Mechanistic studyT2D & other

  2. Diabetes Obes Metab

    Lorcaserin induces abdominal fat loss with associated improvements of the circulating metabolome/lipidome and no changes in the myostatin–activin–follistatin– IGF ‐1 axes: A 6‐month long randomized placebo‐controlled clinical trial

    Randomized controlled trialObesity

  3. Diabetes Obes Metab

    SGLT2 inhibitors and mortality in older adults with diabetic kidney disease: A target trial emulation study

    Cohort studyT2D & other

  4. Diabetes Obes Metab

    Efficacy and safety of once‐weekly insulins in type 2 diabetes: A systematic review and meta‐analysis

    Meta-analysisT2D & other

  5. Diabetes Obes Metab

    Comparative effectiveness of GLP ‐1 receptor agonists, SGLT2 inhibitors and DPP ‐4 inhibitors on liver outcomes in metabolic dysfunction‐associated steatotic liver disease: A retrospective cohort study

    Cohort studyT2D & other

  6. Diabetes Obes Metab

    Lipoprotein(a) is associated with ASCVD in individuals with non‐diabetes, prediabetes, or diabetes independent of CRP

    Cohort studyT2D & other

  7. Diabetes Obes Metab

    Longitudinal exposure to non‐ HDL ‐C and cardiovascular events, all‐cause mortality in type 2 diabetes: A post hoc analysis of the ACCORD trial

    Secondary analysisT2D & other

  8. Diabetes Obes Metab

    GLP ‐1 receptor agonists and cardiovascular outcomes in Asian, Black or African American, and White populations: An updated meta‐analysis including the SOUL trial

    Meta-analysisT2D & other

  9. Diabetes Obes Metab

    Sex differences in patterns of chronic kidney disease care in Australian primary care: A retrospective cohort study of a national general practice dataset

    Cohort study

  10. Diabetes Obes Metab

    Association between daily steps, diabetes management and health indicators in people living with type 1 diabetes: A cross‐sectional study from the BETTER registry

    Cross-sectional studyT1D

  11. Diabetes Obes Metab

    Association of metabolic obesity phenotypes with cognitive decline in the ELSA ‐Brasil study

    Cohort studyObesity

  12. Diabetes Obes Metab

    Risk of acute pancreatitis with DPP ‐4 inhibitors versus SGLT2 inhibitors in medication‐naïve individuals with diabetes: A target trial emulation

    Cohort studyT2D & other

  13. Diabetes Obes Metab

    Efficacy and safety of switching basal insulin to insulin glargine 300 U/ mL in individuals with inadequately controlled type 2 diabetes on advanced insulin therapies: The Toujeo‐Neo T2DM study

    Cohort studyT2D & other

  14. Diabetes Obes Metab

    Cardiovascular outcomes under hypothetical blood‐pressure‐lowering intervention in type 2 diabetes: A target trial emulation

    Research articleT2D & other

  15. Diabetes Obes Metab

    Clinical outcomes of adults with type 1 diabetes and comorbid depression and/or anxiety disorders using hybrid closed‐loop: A retrospective study from a multidisciplinary tertiary centre

    Cohort studyTechnology

  16. Diabetes Obes Metab

    Eloralintide, a selective, long‐acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept

    Randomized controlled trialObesity

  17. Diabetes Obes Metab

    Efficacy of once‐weekly insulin efsitora versus once‐daily basal insulin in type 2 diabetes: A systematic review and meta‐analysis

    Meta-analysisT2D & other

  18. Diabetes Obes Metab

    Preferences for basal insulin treatments in adults with type 2 diabetes: A discrete choice experiment in France and Spain

    Research articleT2D & other

  19. Diabetes Obes Metab

    Dynamic functional network connectivity alterations in obesity

    Cross-sectional studyObesity

  20. Diabetes Obes Metab

    Metformin attenuates metabolic insulin sensitivity and insulin‐stimulated carbohydrate oxidation after high‐intensity exercise training in adults at risk for metabolic syndrome

    Randomized controlled trialT2D & other

  21. Diabetes Obes Metab

    Effectiveness and adherence in a tirzepatide‐supported digital weight‐loss programme in Australia: A real‐world observational study

    Cohort studyObesity

  22. Diabetes Obes Metab

    Reallocating morning physical activity to later‐day activity and its association with type 2 diabetes incidence: The Maastricht Study

    Cohort studyT2D & other

  23. Diabetes Obes Metab

    Comparative prognostic value of nine cardiorenal biomarkers for mortality among adults with prediabetes and diabetes

    Cohort studyT2D & other

  24. Diabetes Obes Metab

    Prediction of heart failure as the first major cardiovascular disease event in type 2 diabetes

    Secondary analysisComplications

  25. Diabetes Obes Metab

    A systematic review of glucocorticoid use in type 1 diabetes: Glycaemic effects and clinical management strategies

    Meta-analysisT1D

  26. Diabetes Obes Metab

    Long‐acting insulin analogues and the risk of diabetic nephropathy among patients with type 2 diabetes: A population‐based cohort study

    Cohort studyT2D & other

  27. Diabetes Obes Metab

    Change in body mass index and disease burden among people with obesity and multiple long‐term conditions

    Cohort studyObesity

  28. Diabetes Obes Metab

    Changes in how people living with obesity perceive weight‐related discussions with their healthcare professional : Results from the cross‐sectional online ACTION ‐ DK 2022 and 2024 studies

    Cross-sectional studyObesity

  29. Diabetes Obes Metab

    Modification of the association between obesity phenotypes and cardiovascular disease by social determinants of health: A prospective cohort study

    Cohort studyObesity

  30. Diabetes Obes Metab

    Novel metabolic syndrome subgroups and their association with cardiovascular outcomes: A data‐driven cluster analysis of the UK Biobank

    Cohort study

  31. Diabetes Obes Metab

    Pharmacokinetics and safety of HR17031 , a fixed‐ratio of INS068 /Noiiglutide combination, in Chinese patients with hepatic impairment

    Research article

  32. Diabetes Obes Metab

    Efficacy of liraglutide on metabolic and reproductive outcomes in women with polycystic ovary syndrome: A systematic review and meta‐analysis

    Meta-analysisReproductive endocrine

  33. Diabetes Obes Metab

    Sex differences in trial representation and the cardiovascular effectiveness of newer glucose‐lowering agents in patients with and without type 2 diabetes: A systematic review and meta‐analysis of cardiovascular outcome trials

    Meta-analysisT2D & other

  34. Diabetes Obes Metab

    Comparison of cardiovascular outcomes between once‐weekly semaglutide and dulaglutide in adults with type 2 diabetes and established atherosclerotic cardiovascular disease in the United States

    Cohort studyT2D & other

  35. Diabetes Obes Metab

    GLP1 ‐ 1RAs improve walking distance and reduce amputation in people with type 2 diabetes and peripheral artery disease: A systematic review and meta‐analysis of randomised controlled trials and cohort studies

    Meta-analysisT2D & other

  36. Diabetes Obes Metab

    Long‐term effects of a multidomain intervention on cognitive function and metabolic control in older adults with type 2 diabetes and mild cognitive impairment: A 42‐month follow‐up of the J‐ MIND ‐Diabetes study

    Randomized controlled trialT2D & other

  37. Diabetes Obes Metab

    Pharmacokinetic properties of insulin GZR4 after subcutaneous administration in the thigh, abdomen, or upper arm in healthy participants

    Randomized controlled trialT2D & other

  38. Diabetes Obes Metab

    Psychosocial outcomes among adults with type 1 diabetes using a tubeless automated insulin delivery system compared with sensor augmented pump therapy: A randomised, parallel‐group clinical trial sub‐study

    Secondary analysisTechnology

  39. Diabetes Obes Metab

    Elevated triglyceride‐glucose index is associated with increased risk of chronic kidney disease and end‐stage renal disease in type 1 diabetes: Nationwide cohort study

    Cohort studyComplications

  40. Diabetes Obes Metab

    Independent associations of mental health and diabetes complications with health‐related quality of life: Evidence from a cross‐sectional study

    Cross-sectional studyComplications

All 2,200 Briefs in ExploreShowing Briefs 641–680 of 2,200, newest first